Literature DB >> 11802116

Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment.

Catherine Champi1.   

Abstract

Primary immunodeficiencies in children are rare, but an early diagnosis can improve long-term quality of life and prevent rapid deterioration of the immune system. More than 70 immunodeficiency diseases have been identified and are classified according to the areas of the immune system that are compromised. When a suspicious history or an uninterrupted pattern of infections leads the practitioner to suspect immunodeficiency, it is essential that proper immunologic testing be initiated as soon as possible. Once a diagnosis is established, the practitioner and a team of experts all are involved in the multidisciplinary treatment, counseling, and longitudinal care of children with primary immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802116

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  13 in total

1.  Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007.

Authors:  Lisa Kobrynski; Rachel Waltenburg Powell; Scott Bowen
Journal:  J Clin Immunol       Date:  2014-09-26       Impact factor: 8.317

2.  Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg.

Authors:  Serge Sultan; Émélie Rondeau; Marie-Claude Levasseur; Renée Dicaire; Hélène Decaluwe; Élie Haddad
Journal:  J Clin Immunol       Date:  2017-06-08       Impact factor: 8.317

3.  Primary immunodeficiency disorders: survey of pediatricians in Kuwait.

Authors:  Waleed Al-Herz; Mohammad E Zainal; Mohammad Salama; Wafa Al-Ateeqi; Khalid Husain; Majeda Abdul-Rasoul; Bander Al-Mutairi; Mona Badawi; Najwa Aker; Subodh Kumar; Haitham Al-Khayat
Journal:  J Clin Immunol       Date:  2008-03-19       Impact factor: 8.317

Review 4.  Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.

Authors:  P Wood; S Stanworth; J Burton; A Jones; D G Peckham; T Green; C Hyde; H Chapel
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

5.  Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran.

Authors:  Mahnaz Sadeghi Shabestari; Seyyed Hadi Maljaei; Reza Baradaran; Mohammad Barzegar; Fazileh Hashemi; Adel Mesri; Nima Rezaei
Journal:  J Clin Immunol       Date:  2007-06-22       Impact factor: 8.317

6.  Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin.

Authors:  Anders Fasth; Jeanette Nyström
Journal:  J Clin Immunol       Date:  2008-02-07       Impact factor: 8.317

7.  Primary immunodeficiency diseases in Egyptian children: a single-center study.

Authors:  Shereen M Reda; Hanaa M Afifi; Mai M Amine
Journal:  J Clin Immunol       Date:  2008-11-11       Impact factor: 8.317

8.  History of primary immunodeficiency diseases in iran.

Authors:  Asghar Aghamohammadi; Mostafa Moin; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

9.  Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry.

Authors:  Nima Rezaei; Asghar Aghamohammadi; Mostafa Moin; Zahra Pourpak; Masoud Movahedi; Mohammad Gharagozlou; Lida Atarod; Bahram Mirsaeid Ghazi; Anna Isaeian; Maryam Mahmoudi; Kamran Abolmaali; Davoud Mansouri; Saba Arshi; Naser Javaher Tarash; Roya Sherkat; Hedayat Akbari; Reza Amin; Abdolvahab Alborzi; Sara Kashef; Reza Farid; Iraj Mohammadzadeh; Mehrnaz Sadeghi Shabestari; Mohammad Nabavi; Abolhassan Farhoudi
Journal:  J Clin Immunol       Date:  2006-10-06       Impact factor: 8.542

10.  Clinical predictors of primary immunodeficiency diseases in children.

Authors:  Shereen M Reda; Dalia H El-Ghoneimy; Hanaa M Afifi
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-02       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.